These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37205500)

  • 41. Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings.
    Dziopa K; Asselbergs FW; Gratton J; Chaturvedi N; Schmidt AF
    Diabetologia; 2022 Apr; 65(4):644-656. PubMed ID: 35032176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older.
    Neumann JT; Riaz M; Bakshi A; Polekhina G; Thao LTP; Nelson MR; Woods RL; Abraham G; Inouye M; Reid CM; Tonkin AM; McNeil J; Lacaze P
    Circ Genom Precis Med; 2022 Feb; 15(1):e003429. PubMed ID: 34949098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polygenic risk score validation using Korean genomes of 265 early-onset acute myocardial infarction patients and 636 healthy controls.
    Bhak Y; Jeon Y; Jeon S; Yoon C; Kim M; Blazyte A; Kim Y; Kang Y; Kim C; Lee SY; Bae JW; Kim W; Kim YJ; Shim J; Kim N; Chun S; Kim BC; Kim BC; Lee S; Bhak J; Shin ES
    PLoS One; 2021; 16(2):e0246538. PubMed ID: 33539413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genome-wide polygenic risk score, cardiometabolic risk factors, and type 2 diabetes mellitus in the Chinese population.
    Huang N; Xiao W; Lv J; Yu C; Guo Y; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Avery D; Ou T; Chen J; Chen Z; Huang T; Li L;
    Obesity (Silver Spring); 2023 Oct; 31(10):2615-2626. PubMed ID: 37661427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of Major Adverse Cardiovascular Events From Retinal, Clinical, and Genomic Data in Individuals With Type 2 Diabetes: A Population Cohort Study.
    Mordi IR; Trucco E; Syed MG; MacGillivray T; Nar A; Huang Y; George G; Hogg S; Radha V; Prathiba V; Anjana RM; Mohan V; Palmer CNA; Pearson ER; Lang CC; Doney ASF
    Diabetes Care; 2022 Mar; 45(3):710-716. PubMed ID: 35043139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses.
    Sun L; Pennells L; Kaptoge S; Nelson CP; Ritchie SC; Abraham G; Arnold M; Bell S; Bolton T; Burgess S; Dudbridge F; Guo Q; Sofianopoulou E; Stevens D; Thompson JR; Butterworth AS; Wood A; Danesh J; Samani NJ; Inouye M; Di Angelantonio E
    PLoS Med; 2021 Jan; 18(1):e1003498. PubMed ID: 33444330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic Importance of Genomic and Clinical Risk for Coronary Artery Disease Over the Life Course.
    Urbut SM; Cho SMJ; Paruchuri K; Truong B; Haidermota S; Peloso G; Hornsby W; Philippakis A; Fahed AC; Natarajan P
    medRxiv; 2023 Nov; ():. PubMed ID: 37961553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes.
    Lu T; Forgetta V; Yu OHY; Mokry L; Gregory M; Thanassoulis G; Greenwood CMT; Richards JB
    Cardiovasc Diabetol; 2020 Jan; 19(1):12. PubMed ID: 32000781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of coronary computed tomography or polygenic risk scores to prompt action to reduce coronary artery disease risk: the CAPAR-CAD trial.
    Verma KP; Marwick TH; Duarte C; Meikle P; Inouye M; Carrington MJ
    Am Heart J; 2022 Jun; 248():97-107. PubMed ID: 35218726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neural network-based integration of polygenic and clinical information: development and validation of a prediction model for 10-year risk of major adverse cardiac events in the UK Biobank cohort.
    Steinfeldt J; Buergel T; Loock L; Kittner P; Ruyoga G; Zu Belzen JU; Sasse S; Strangalies H; Christmann L; Hollmann N; Wolf B; Ference B; Deanfield J; Landmesser U; Eils R
    Lancet Digit Health; 2022 Feb; 4(2):e84-e94. PubMed ID: 35090679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study.
    Nair R; Mody R; Yu M; Cowburn S; Konig M; Prewitt T
    Diabetes Ther; 2022 Dec; 13(11-12):1921-1932. PubMed ID: 36131064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polygenic risk scores for coronary artery disease and subsequent event risk amongst established cases.
    Howe LJ; Dudbridge F; Schmidt AF; Finan C; Denaxas S; Asselbergs FW; Hingorani AD; Patel RS
    Hum Mol Genet; 2020 May; 29(8):1388-1395. PubMed ID: 32219344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction.
    Riveros-Mckay F; Weale ME; Moore R; Selzam S; Krapohl E; Sivley RM; Tarran WA; Sørensen P; Lachapelle AS; Griffiths JA; Saffari A; Deanfield J; Spencer CCA; Hippisley-Cox J; Hunter DJ; O'Sullivan JW; Ashley EA; Plagnol V; Donnelly P
    Circ Genom Precis Med; 2021 Apr; 14(2):e003304. PubMed ID: 33651632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
    Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
    Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient Implementation of Penalized Regression for Genetic Risk Prediction.
    Privé F; Aschard H; Blum MGB
    Genetics; 2019 May; 212(1):65-74. PubMed ID: 30808621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Donor and recipient polygenic risk scores influence the risk of post-transplant diabetes.
    Shaked A; Loza BL; Van Loon E; Olthoff KM; Guan W; Jacobson PA; Zhu A; Fishman CE; Gao H; Oetting WS; Israni AK; Testa G; Trotter J; Klintmalm G; Naesens M; Asrani SK; Keating BJ
    Nat Med; 2022 May; 28(5):999-1005. PubMed ID: 35393535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.
    Lopez-Pineda A; Vernekar M; Moreno-Grau S; Rojas-Muñoz A; Moatamed B; Lee MTM; Nava-Aguilar MA; Gonzalez-Arroyo G; Numakura K; Matsuda Y; Ioannidis A; Katsanis N; Takano T; Bustamante CD
    Hum Genomics; 2022 Sep; 16(1):37. PubMed ID: 36076307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variation in cardiovascular disease risk factors among older adults in the Hunter Community Study cohort: A comparison of diet quality versus polygenic risk score.
    Reay WR; Haslam R; Cairns MJ; Moschonis G; Clarke E; Attia J; Collins CE
    J Hum Nutr Diet; 2022 Aug; 35(4):675-688. PubMed ID: 35560851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polygenic Risk Score-Enhanced Risk Stratification of Coronary Artery Disease in Patients With Stable Chest Pain.
    Christiansen MK; Winther S; Nissen L; Vilhjálmsson BJ; Frost L; Johansen JK; Møller PL; Schmidt SE; Westra J; Holm NR; Jensen HK; Christiansen EH; Guðbjartsson DF; Hólm H; Stefánsson K; Bøtker HE; Bøttcher M; Nyegaard M
    Circ Genom Precis Med; 2021 Jun; 14(3):e003298. PubMed ID: 34032468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.
    Yano Y; O'Donnell CJ; Kuller L; Kavousi M; Erbel R; Ning H; D'Agostino R; Newman AB; Nasir K; Hofman A; Lehmann N; Dhana K; Blankstein R; Hoffmann U; Möhlenkamp S; Massaro JM; Mahabadi AA; Lima JAC; Ikram MA; Jöckel KH; Franco OH; Liu K; Lloyd-Jones D; Greenland P
    JAMA Cardiol; 2017 Sep; 2(9):986-994. PubMed ID: 28746709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.